Sponsors
Everything we do at In-House CME is made possible by the organizations that believe in advancing podiatric education. We're grateful to our sponsors for making world-class CME accessible and free to every physician we serve.
PLATINUM
Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion and related midfoot deformities.
Sanuwave
Sanuwave is a regenerative medicine company specializing in non-invasive wound care technologies, with UltraMIST as its flagship solution for accelerating healing of chronic wounds. Sanuwave delivers innovative, evidence-based therapies that restore the body’s natural healing processes. Its core offering, UltraMIST, is an FDA-cleared, low-frequency ultrasound therapy that uses a fine saline mist to deliver energy deep into tissue—stimulating circulation, reducing bacterial load, and promoting new cell growth without pain or contact. UltraMIST is safe, reimbursable under Medicare Part B, and has been successfully used in millions of treatments across leading health systems.
Alfasigma USA
Alfasigma USA is a specialty pharmaceutical company dedicated to advancing purposeful nutrition through science-driven medical food solutions. Our portfolio includes three clinically studied medical food brands: Metanx® for the clinical dietary management of peripheral neuropathy, Deplin® for the clinical dietary management of depression, and Cerefolin Brain Wellness® for the clinical dietary management of mild cognitive impairment. New MetanxPRO Nerve Health™ builds on the trusted Metanx® legacy and now includes Acetyl-L-carnitine to further support nerve energy production and repair to help reduce nerve discomfort in as little as 14 days.
GOLD
MolecuLight
MolecuLight is a global leader in advanced wound imaging, transforming point of care decision making with an all-in-one imaging platform designed specifically for wound assessment. Our FDA cleared Class II devices, the MolecuLight i:X® and DX®, enable clinicians to instantly detect elevated bacterial burden in real time and capture precise digital wound measurements, empowering more informed treatment decisions at the bedside. The MolecuLightDX+® further enhances assessment capabilities with integrated thermal imaging, supporting a more comprehensive evaluation of complex wounds. Backed by more than 100 peer reviewed publications, MolecuLight technology is clinically validated to improve diagnostic confidence, optimize workflow efficiency, and support better patient outcomes.
